BioSpace News Archive

Insightec: The TFDA Approved Exablate Neuro for the Treatment of Essential Tremor

The approval was based on data from a randomized, double-blind clinical study conducted in eight medical centers in North America and Asia.

November 29, 2017
·
2 min read
Business

Aethlon Medical Names Dr. Charles J. Fisher Chairman of the Board

The Aethlon Board of Directors unanimously nominated Dr. Fisher to be non-Executive Chairman and he will remain an independent director under Nasdaq rules.

November 29, 2017
·
6 min read
BioForest

Frazier-Backed Mavupharma Scores $20M to Fund STING Program

The Series A funding will be used primarily to advance Mavu’s lead drug candidates into the clinic.

November 29, 2017
·
2 min read
Drug Development

Inovio’s Further Analysis of VGX-3100 Phase IIb Data Reveals Immune Correlates and Biomarker Signatures That Predicted Clinical Efficacy

Inovio continues to investigate pre-treatment biomarkers which could identify patients most likely to respond to treatment with VGX-3100, increasing absolute efficacy of the product.

November 29, 2017
·
9 min read
Genetown

CardioFocus Completes Successful Controlled U.S. Commercial Launch of the HeartLight System

CardioFocus today announced the successful completion of its controlled U.S. commercial launch of the HeartLight Endoscopic Ablation System for the treatment of paroxysmal atrial fibrillation.

November 29, 2017
·
3 min read
Business

Mitra Biotech Partners With Gotect Diagnostic in Israel

Mitra Biotech today announced an agreement with Gotect Diagnostic for the exclusive right to represent Mitra in Israel.

November 29, 2017
·
2 min read
Phyton Biotech Wins Grant to Develop New Approaches to Manufacturing Artemisinin

Bill & Melinda Gates Foundation invests in R&D pilot for anti-malarial active pharmaceutical ingredients.

November 29, 2017
·
3 min read